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tumours, to determine the suitability of these markers for assessing prognosis. Methods-This was a prospective observational study undertaken in a gynaecological oncology centre: 57 women with primary cervical cancer and 42 with recurrent disease were recruited between January 1990 and September 1992. Kaplan-Meier survival analysis with the log rank test was used to assess survival differences with survival rate given per year of follow up. Results-In primary disease, the four year survival for the P-core negative group was 79%, compared with 14% for the P-core positive group (p = 0.001). This was still significant for early stage disease or squamous lesions alone. In recurrent disease, P-core positivity was not prognostically significant. Immunohistochemistry was of no prognostic significance in either group.
Conclusions-p-core excretion appears to be useful in assessing prognosis of primary cervical cancer but not of recurrent disease. A large prospective study of urinary P-core in early stage cervical cancer is needed to determine whether it can be used as an index for modifying treatment. ( The slides were scored visually by two independent observers (RAFC, CJC) for granular cytoplasmic staining. The case was scored positive if any tumour cell showed positive staining.
P-CORE ESTIMATION
All women provided a urine sample at their initial attendance. Specimens with a creatinine concentration greater than 4 mmol/litre were assayed for P-core as described"; values were considered raised if they were above the 90th centile for the relevant group (premenopausal 0.034 ng 1-core/ml/mmol creatinine; postmenopausal 0.094 ng 1-core/ml/mmol creatinine). Forty six women with primary disease and 38 women with recurrent cervical cancer had sufficiently concentrated urine for P-core estimation. PATIENT Nineteen cases were 13hCG negative by immunohistochemistry from material collected at the time of the recurrence and 10 were positive. In this group, immunohistochemistry was of no prognostic significance, either alone or in combination with P-core.
Discussion
Our previous study'" showed that 1-core is a useful short term prognostic marker in primary cervical cancer (18 months of follow up). Our present report now extends and confirms these findings with a larger group and longer follow up period. This is particularly important in cervical carcinoma, as most recurrences (treatment failure and persistent disease) will present within the first two years'3 14 and so may have been missed in the earlier study.
In the group of women who had recurrent disease, 1-core was of no prognostic value. As the recurrent group is a selected subset with a very poor outcome, the higher number of positives is not unexpected. The urine samples of 11 of the 57 patients with primary cancer and four of the 42 patients with recurrent cancer were too dilute for 1-core analysis. This may have introduced bias, but as the samples were analysed in batches it was not possible to collect further specimens from these patients. A tissue specimen is always taken at the time of diagnosis of primary and recurrent disease.
The presence of 1hCG can be detected using immunohistochemistry and might obviate the need for a urine test (13-core) . However, in the present study PhCG staining was of no prognostic value in any group. This might be related to technical problems, although we used an appropriate antigen retrieval method.'2 The more likely explanation is that ,BhCG is released rapidly following synthesis with little or no storage in the cell, and a random section of the tumour will be unlikely to contain more than a few positive cells at most. The small amount of staining in cases which were counted as positive is in contrast to positive transitional cell bladder carcinomas which show widespread staining. This suggests that the positive areas might represent non-specific staining. In colorectal cancer, the prognostic significance of raised serum 13hCG as a tumour marker was significant for poor outcome8 while immunohistochemical staining was of no value.'7 These findings are reflected in our study.
The expression of PhCG is stage related.4 Two of the three women who were 1-core positive in the early stage subset of the primary group had involved pelvic lymph nodes. Therefore, larger numbers are required to determine whether the 1-core expression and poor outcome are related to a larger tumour volume rather than to more aggressive disease. With the increased effectiveness of the United Kingdom national cervical screening programme, there has been a considerable fall in mortality and a reduction in the frequency of advanced disease. ' 
